Healthcare Pharmaceutical Biotech

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions

August 31, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its Atenolol tablets of 25mg, 50mg and 100mg for the Canadian market. Atenolol is the generic equivalent of the brand name, Tenormin®. Atenolol belongs to a class of drugs known as beta-blockers. It works by blocking the action of certain natural chemicals...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing

August 31, 2026 8:47 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that its MDCE Melanoma Scan Beta platform is seeking its first set of volunteers for human-submitted dataset testing - a significant step beyond the Company's prior work training and evaluating models solely on established public cancer imaging datasets. Until now, development of MDCE Melanoma Scan Beta has centered on structured internal testing and AI model optimization using...

Read more

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

August 31, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, provides an update on its Measles Drug Treatment Program. While CDC is reviewing the two recent measles-related fatalities in Pennsylvania, the total number of confirmed measles cases in the USA...

Read more

Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study

August 31, 2026 8:30 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on complex pain, and advancing next-generation pain and central nervous system therapeutics designed to reduce abuse and overdose risk, today announced completion of enrollment in the final stage of the PF614-MPAR-102 clinical study. The study evaluated its novel...

Read more

UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)

August 31, 2026 5:30 AM

BioAdaptives®, Inc. (OTCID:BDPT) announced today that UFC Hall of Famer and former UFC middleweight champion Michael Bisping has joined MyndSystem™ as a paid brand ambassador. The partnership will focus on promoting MyndMed™ and MyndRenew™, the products at the core of the MyndSystem™ platform. The campaign will focus on education, real-world routines, and demonstrating how MyndSystem™ fits into Bisping's hectic schedule. Approved content for...

Read more

New Number of Shares and Votes in IRLAB Therapeutics AB

August 31, 2026 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - During August 2026, the registered number of shares and votes in IRLAB Therapeutics AB ("IRLAB" or the "Company") has changed as a result of the Company's recently completed rights issue and overallotment issue of ordinary shares of series A, which the Board of Directors resolved on 5 May 2026 and which were approved by the Extraordinary General Meeting on 5 June 2026. As of 31 August 2026, the total...

Read more

ESA Letter for Dog: RealESALetter.com Trusted by US Residents

August 29, 2026 8:40 AM

For people who rely on the companionship of a dog for emotional support, understanding the difference between an emotional support animal and an ordinary pet is an important first step. An ESA letter is professional documentation that may support a reasonable housing accommodation when an individual qualifies under applicable fair housing laws. RealESALetter.com provides an online process that connects applicants with licensed mental health...

Read more

Bionic Bloom Integrated Health Welcomes Kathryn Silver, MA, RMHCI as New Art Therapy Provider

August 29, 2026 7:00 AM

Bloom Integrated Health, home to Bionic Bloom and the Neurodivergent Empowerment Institute (NEI), today announced that St. Petersburg-based Kathryn A. Silver, MA, RMHCI has joined its team as a new therapy provider. Silver is an experienced art therapist whose career spans community mental health, private practice, inpatient treatment, school-based behavioral health and cancer care. Her work incorporates creative expression with trauma-informed...

Read more

DirectMax Reviews 2026: Could Direct Meds' 3-Ingredient Sublingual Option Be the Men's Wellness Upgrade You've Been Looking For?

August 28, 2026 9:20 PM

Quick disclosure before you read further: This is a paid advertorial. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. DirectMax is marketed by Direct Meds as a prescription-only compounded medication. Prescription medication is available only after consultation and approval by a licensed healthcare provider, if clinically appropriate. Approval is...

Read more

Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera

August 28, 2026 8:30 PM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") announced today that Takeda received U.S. Food and Drug Administration (FDA) approval for MIMRYLO (rusfertide), a subcutaneously delivered first-in-class hepcidin mimetic peptide for the treatment of erythrocytosis in adults with polycythemia vera (PV). MIMRYLO is the first and only hepcidin mimetic approved for polycythemia vera (PV), a blood cancer characterized by...

Read more

CVS Pharmacy(R) and MinuteClinic(R) Now Offering Updated Flu Vaccines Nationwide

August 28, 2026 9:00 AM

CVS Health® (NYSE:CVS) announced that updated 2026-2027 flu vaccines are now available at CVS Pharmacy® and MinuteClinic® locations nationwide. According to the Centers for Disease Control and Prevention (CDC), annual flu vaccination is one of the most effective ways to help reduce the risk of flu-related illness and complications. Patients can schedule vaccination appointments online at CVS.com, MinuteClinic.com or through the CVS Health app....

Read more

Dr. Irfan Atcha Marks 30 Years in Chicago Implant Dentistry

August 28, 2026 8:45 AM

Dr. Irfan Atcha is marking 30 years of practising dentistry in Chicago, reaching a career milestone that spans major changes in dental implant technology, treatment planning, and approaches to complex dental rehabilitation. Atcha began practising in Chicago in 1996 after earning his Doctor of Dental Surgery degree from the University of Illinois College of Dentistry. Over the three decades since, his work has become increasingly focused on...

Read more

Tenon Medical Announces Pricing of $3M Private Placement Offering

August 28, 2026 8:15 AM

Tenon Medical, Inc. (NASDAQ:TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that on August 27, 2026 it has entered into a securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private...

Read more

Medical Aesthetics by Lacey Adds Tixel 2 to Expand Its Skin Rejuvenation Services

August 28, 2026 7:20 AM

Medical Aesthetics by Lacey, a boutique aesthetics practice serving clients in Honeoye Falls, Mendon, Victor, and surrounding communities, announced the addition of Tixel 2 to its growing range of cosmetic and skin rejuvenation treatments. Tixel 2 is an FDA-cleared fractional skin resurfacing system that uses proprietary Thermo-Mechanical Action (TMA) technology. Unlike laser or light-based resurfacing systems, Tixel 2 delivers controlled...

Read more

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

August 28, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) ("Moderna"), today announced the pricing of $2.6 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the "notes") in a private placement (the "offering") only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously announced offering size of...

Read more

Bionic Bloom Integrated Health Welcomes Celeste Verastegui as New Provider

August 28, 2026 7:00 AM

Bloom Integrated Health, home to Bionic Bloom and the Neurodivergent Empowerment Institute (NEI), today announced that St. Petersburg-based Celeste Verastegui has joined its team as a new therapy provider. Verastegui is a multi-lingual vibrational therapist and educator whose work integrates sound, energy and presence to support personal healing and reconnection. Her approach incorporates Tibetan singing bowls, sound healing, Reiki, breathwork...

Read more

Massachusetts Man Marks 50 Consecutive Years of Labor Day Fundraising for Muscular Dystrophy Association

August 28, 2026 7:00 AM

In 1976, a young Jay Tolman gathered friends under a tent in his mother's backyard in Hingham, Massachusetts, to raise money for the Muscular Dystrophy Association (MDA). Inspired by Jerry Lewis and his legendary Labor Day MDA Telethon, they raised $50. Tolman never stopped. On Sunday, September 6, Tolman, his family, friends and supporters will gather in Hingham for the 50th consecutive year of the Annual Tolman MDA Telethon fundraiser he...

Read more

Veterans and Military Families Get More Access to Ketamine-Based Mental Health Care for PTSD Across Tampa Bay

August 28, 2026 6:00 AM

Bloom Integrated Health (BIH) today announced that it accepts TRICARE insurance for eligible covered mental health services provided within individualized treatment plans, including plans that may incorporate self-pay ketamine-based care for post-traumatic stress disorder (PTSD). This approach provides eligible service members, veterans, military retirees and their families with a more affordable path to mental health care across Tampa Bay....

Read more

DC Healthcare Q2 EBITDA Surges to RM2.91 Million on Stronger Operating Performance

August 28, 2026 5:40 AM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specialising in non-invasive and minimally invasive procedures, today announced its financial results for the second quarter ended 30 June 2026 ("Q2 FY2026"), delivering higher revenue and a strong year-on-year improvement in operating performance, with earnings before interest, tax, depreciation and amortisation ("EBITDA") rising significantly...

Read more

Cantargia to Participate in Upcoming Investor Conferences

August 28, 2026 5:20 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA) today announced that management will participate in the following investor conferences during September 2026. H.C. Wainwright - 28th Annual Global Investment Conference 2026, New York Company Presentation by Hilde Steineger, CEO Investor meetings September 14 at 10.30 am ET (16.30pm CEST). Biostock - Investing in Life Sciences, IVA Konferens, Stockholm Presentation by Hilde Steineger, CEO September 22...

Read more